McGuire Annie, EVP, GC, reported an open-market or private sale at VERACYTE, INC. involving 2154.000000 shares for an estimated $92173.11. Reported holdings after the transaction were 132260.000000 shares. The stored filing text includes a detected 10b5-1 reference.
Stored Form 4 columns with their raw values
Badges describe filing facts only — not predictions.
Compact filing score computed from stored Form 4 facts. Version v1.
This filing is broadly neutral on the filing-only scale. The Form 4 facts do not strongly tilt positive or negative.
Form 4 relationship flags and nearby filing context
EVP, General Counsel
Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on September 2, 2026 and does…
Includes 389 shares of common stock purchased on July 31, 2026 pursuant to the Veracyte, Inc. Employee Stock Purchase Plan.
The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 29, 2025.
Represents weighted average sales price. Sale prices for the transactions range from $42.49 to $43.38. Detailed information regarding the number of shares sold at each separate price will be provide…
Represents weighted average sales price. Sale prices for the transactions range from $43.50 to $44.16. Detailed information regarding the number of shares sold at each separate price will be provide…
0 other filings
0 recent txs